Showing 1111-1120 of 6766 results for "".
Sunscreen Water Seems All Washed Up; Fake Cosmeceuticals Raise Concerns
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-sunscreen-water-seems-all-washed-up-fake-cosmeceuticals-raise-concerns/19119/In this edition of DermWireTV, from the publishers of Practical Dermatology® magazine we take a look at drinkable sunscreen and school bans on sunscreens, get an update on Vegas Cosmetic Surgery, and meet the new face of AMBI skincare. Plus, our DermFocus investigates the problem of counterfeit cosSINON by Quantel Derma
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/sinon-by-quantel-derma/19387/The ruby laser system with active Q-switch against natural pigmentations and tattoos. The Q-switched ruby laser system SINON has a wavelength of 694 nm. It applies ultra short pulses of only 20 ns for effective treatments even with low fluency. Thus, SINON is fast, reliable and gentle and able to rHoya ConBio - The Medlite Peel
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/hoya-conbio-the-medlite-peel/19455/A specific patient case is demonstrated to show the outcome of using the Medlite as a laser peel. Valuable tips and suggestions are given by Dr. Brian Rubach.June Issue: Melanoma Updates - Epidemiology, Diagnostics, and Treatment
https://practicaldermatology.com/issues/may-june-2025/melanoma-updates-epidemiology-diagnostics-and-treatment/35917/In this article, we review the latest changes in melanoma incidence and mortality, highlight key disparities among minority populations, and summarize emerging trends in technology and treatment that are reshaping the future of melanoma care.Study Examines Association Between Childhood BMI and Risk of Developing IMSDs
https://practicaldermatology.com/series/dermwire-tv/study-examines-association-between-childhood-bmi-and-risk-of-developing-imsds/27004/In this week's DermwireTV, a new study examines the relationship between childhood BMI and skin diseases; phase 3 data sheds new light on dupilumab’s effect on inflammatory biomarkers in pediatric AD patients; and the president and CEO of Evolus discusses trends in the injectables market.FDA Approval for Delgocitinib
https://practicaldermatology.com/series/c-suite-chats/fda-approval-for-delgocitinib/36650/Robert Spurr, EVP, North America for LEO Pharma, discusses the importance of an FDA-approved option for treating moderate-to-severe chronic hand eczema in adults.New Treatment Option for Androgenetic Alopecia
https://practicaldermatology.com/series/c-suite-chats/new-treatment-option-for-androgenetic-alopecia/32969/Reid Waldman, MD, Co-Founder and CEO of Veradermics, discusses the prevalence of androgenetic alopecia-pattern hair loss and the company's investigational treatment candidate.Journal Scan of Three Trials for an Rx Option
https://practicaldermatology.com/topics/psoriasis/deucravacitinib-journal-scan/29155/A review of three clinical trials, with introduction and commentary by Linda Stein Gold, MD. Click the image to download the full supplement.Noah Worcester 2024: Dr. Bettencourt on Beach Vacations
https://practicaldermatology.com/conferences/noah-worcester-2024/noah-worcester-2024-dr-bettencourt-beach-vacations/24591/Miriam Bettencourt, MD, summarizes her lecture about problems that can be encountered during beach vacations at the 2024 Noah Worcester Dermatological Society meeting.Advances in Topicals for Skin Conditions
https://practicaldermatology.com/topics/psoriasis/advances-in-topicals-for-skin-conditions/20197/There are more topicals available today than ever before for acne, rosacea, and psoriasis, and even more are coming down the pike. Larry Green, MD, reviews the current topical landscape in dermatology and previews what’s in the pipeline.